{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-157940","form_type":"8-K","ticker":"XLO","cik":"0001840233","company_name":"Xilio Therapeutics, Inc.","filed_at":"2026-04-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.085719+00:00","generated_at":"2026-05-15T05:51:16.326236+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Xilio Therapeutics appoints Cheryl Blanchard to Board; Rossi resigns","bullets":["Cheryl Blanchard elected as Class III director effective April 15, 2026; term expires at 2027 annual meeting.","Blanchard appointed chair of Compensation Committee and member of Audit Committee.","Blanchard receives $40k annual cash retainer, $12k for Comp chair, $7.5k for Audit; initial option for 10k shares vesting over 3 years.","Christina Rossi resigned from Board on April 15, 2026; resignation not due to any disagreement with company.","Board adopted amended Non-Employee Director Compensation Policy effective April 15, 2026 (Exhibit 10.1)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-157940","json":"https://secwatch.observer/filing/0001193125-26-157940.json","markdown":"https://secwatch.observer/filing/0001193125-26-157940.md","text":"https://secwatch.observer/filing/0001193125-26-157940.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840233/000119312526157940/0001193125-26-157940-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840233/000119312526157940/xlo-20260416.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T05:51:16.326236+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}